Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 12970005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
OBJECTIVE: To assess the role of anaerobic bacteria in acute exacerbation of chronic bronchitis (AECB). METHODS: The level of the Ig-A class to two organisms (Fusobacterium nucleatum and Prevotella intermedia) was determined in the sputum of 25 patients with AECB and 25 control patients. The presence and level of these antibodies were investigated by enzyme-linked immunosorbent assay. RESULTS: The median sputum antibody level for F nucleatum and P intermedia were significantly higher in patients with AECB as compared to control patients (p < 0.05). The IgA levels for F nucleatum was 3.5 times higher in patients with AECB and 3.8 times greater for P intermedia. CONCLUSIONS: This study demonstrates for the first time an elevated sputum antibody titers in patients with AECB to F nucleatum and P intermedia.
Medical subject headings
- Antibodies, Bacterial
- Bronchitis
- Fusobacterium nucleatum
- Immunoglobulin A, Secretory
- Prevotella intermedia
- Pulmonary Disease, Chronic Obstructive
- Sputum